QMed Inc

QMed — Investor Presentation (November 2006)

54 slides from QMed's investor presentation, Nov 9, 2006

  1. Slide 1

    Slide 1

  2. Slide 2: Forward-Looking Statements

    Slide 2: Forward-Looking Statements

    tatements

  3. Slide 3: Special Needs Plans

    Slide 3: Special Needs Plans

    Special Needs Plans

  4. Slide 4: QMed Background

    Slide 4: QMed Background

    QMed Background

  5. Slide 5: QMedCare

    Slide 5: QMedCare

    QMedCare

  6. Slide 6: CMS and Congress

    Slide 6: CMS and Congress

    CMS and Congress Congressional Democrats & Republicans both support SNPs = The importance of being truly “Special” = The contracting model is not in favor in Congress = SNP RAPS eliminates the artificial transfer of funds to traditional MCOs = The care model for the Medicare beneficiary is definitel

  7. Slide 7

    Slide 7

  8. Slide 8

    Slide 8

  9. Slide 9: Medicare Modernization Act

    Slide 9: Medicare Modernization Act

    Medicare Modernization Act = Part D — Pharmacy Benefit = RX Reimbursement for HMO’s = RAPS (Risk Adjusted Premium System) = 2006 - 75% Adjusted = 2007 - 100% Adjusted = Special Needs Plan (SNP) = Duals = Institutionalized = Chronics — CMS Approval

  10. Slide 10: QMedCare Expansion

    Slide 10: QMedCare Expansion

    QMedCare Expansion HMO Expansion = Timing Considerations = HMO License = CMS Approval = New Markets = Population size / Healthcare Systems = Actuarial analysis « Reimbursement / 5% Sample

  11. Slide 11: Subsidiary and Insurance Structure

    Slide 11: Subsidiary and Insurance Structure

    Beg oit Ine > Subsidiary Assumes Underwriting Risk for all costs =» HMO - Certificate of Authority = Captive Insurance Company = LakeShore Captive Insurance Company « Reinsurance Alliance = ACE

  12. Slide 12: Future Opportunities

    Slide 12: Future Opportunities

    Future Opportunities Product Offerings = C3/ RAPS Dual Eligible SNPs = Chronic Dual Eligible SNPs = SNP Partnerships

  13. Slide 13: Early Lessons

    Slide 13: Early Lessons

    Early Lessons

  14. Slide 14: Jane Murray

    Slide 14: Jane Murray

    Jane Murray

  15. Slide 15

    Slide 15

  16. Slide 16

    Slide 16

  17. Slide 17: Keys to Enrollment

    Slide 17: Keys to Enrollment

    s to Enrollment = Meet the needs of hospitals = Meet the needs of physicians Meet the needs of patients = Market, market, market -- intelligently

  18. Slide 18: Benefits to Joining

    Slide 18: Benefits to Joining

    enefits to Joining

  19. Slide 19: Physician Benefits to Joining

    Slide 19: Physician Benefits to Joining

    sician Benefits to Joining = 100% (non-discounted) Medicare rates = One Plan - A, B, D, Supplemental = One Bill — No Deductibles and No co-pays « No Patient A/Rs = No bad debt or write offs = No Referrals = Comprehensive Formulary (100% of top 100 Drugs) = Covers the ‘doughnut hole’ — Brand included

  20. Slide 20

    Slide 20

  21. Slide 21: Proposition

    Slide 21: Proposition

    oposition

  22. Slide 22: Marketing Strategy

    Slide 22: Marketing Strategy

    Marketing Strategy = Consumer focus groups = Key findings = Messaging = Target Part D Rx and supplemental policy holders = Lead Generation = Media = Direct Mail = Pharmacy Meetings = Community Centers = Gated Communities (NJ only) a Partnerships = Walgreen's = Medical groups = Hospital systems

  23. Slide 23

    Slide 23

  24. Slide 24

    Slide 24

  25. Slide 25

    Slide 25

  26. Slide 26: QMed Experience

    Slide 26: QMed Experience

    QMed Experience

  27. Slide 27: Pioneers in DM

    Slide 27: Pioneers in DM

    Pioneers in DM

  28. Slide 28: Experience in Seniors

    Slide 28: Experience in Seniors

    A io ence in Seniors Hospital Days Skilled Nutsing Facies Expected ‘actual ER/Oupatien/Oher

  29. Slide 29: Evidence Based Medicine

    Slide 29: Evidence Based Medicine

    Evidence Based Medicine All Market PCP Acceptance to Recommendations 93% 7 76%, Ischemia” Hypertension Lipid ASA

  30. Slide 30: Evidence Based Medicine

    Slide 30: Evidence Based Medicine

    Evidence Based Medicine Physician Satisfaction (n= 1,287) Quaity of Reports 92% Usefulness of Recommendations 87% Overal Satisfaction 92% Member Satisfaction (n= 17,105) Staff is Helpful 92% Understanding of Program 91% +# of Physicians sampled 6,437 1287 responded f gamates areca Overall Satisfacti

  31. Slide 31: Care Management Engine

    Slide 31: Care Management Engine

    Care Management Engine QMed Nurse UM DM/CM Hospital Phone calls Patient Bh Pharmacy Lab Cee Ise QMed EHR Physician DM Community Coordinated Care Algorithms

  32. Slide 32: Disease States Managed

    Slide 32: Disease States Managed

    Disease States Managed Health Promotion and Prevention Coronary Artery Disease Heart Failure Diabetes Hypertension Stroke COPD and Asthma Hyperlipidemia Obesity/Weight Management

  33. Slide 33: DM Algorithm

    Slide 33: DM Algorithm

    DM Algorithm

  34. Slide 34: Benefits of Optimal Management

    Slide 34: Benefits of Optimal Management

    Benefits of Optimal Management = Decrease healthcare utilization = Optimize healthcare utilization

  35. Slide 35: So, How are we doing

    Slide 35: So, How are we doing

    So, How are we doing Percent 82 5 Actuarial OMLR Current

  36. Slide 36: So, How are we doing ...?

    Slide 36: So, How are we doing ...?

    So, How are we doing ...?

  37. Slide 37: So, How are we doing ...?

    Slide 37: So, How are we doing ...?

    So, How are we doing ...?

  38. Slide 38: So, How are we doing ...?

    Slide 38: So, How are we doing ...?

    So, How are we doing ...? Inpt Inpt SNF SNF (pred) (actual) (pred) (actual) Admit rate‘member (annualized)

  39. Slide 39: So, How are we doing ...?

    Slide 39: So, How are we doing ...?

    So, How are we doing ...?

  40. Slide 40: So, How are we doing ...?

    Slide 40: So, How are we doing ...?

    So, How are we doing ...? 5 vf io 4 2 Inpt Inpt SNF SNF (pred) (actual) (pred) (actual) G Average LOS

  41. Slide 41: So, How are we doing

    Slide 41: So, How are we doing

    So, How are we doing 25 85 _ 845 eas 4 [Sariax Soore __ MUR 2 os Predicted ‘Obeered

  42. Slide 42: So, How are we doing ...?

    Slide 42: So, How are we doing ...?

    So, How are we doing ...? 80 70 60 50 40 30 20 10 0 Percent Morethan6 Morethan3 More than6 drugs disease diseases

  43. Slide 43

    Slide 43

  44. Slide 44

    Slide 44

  45. Slide 45: Transition From Vendor to SNP

    Slide 45: Transition From Vendor to SNP

    Transition From Vendor to SNP = Risks as a middleman = Industry consolidation = Internalizing of DM functions = Aggregator of Premium = Section 231 paves the way = RAPS accelerates top line = Greater Long-Term Growth Opportunities = C-SNPs South Dakota Chronic & Duals = New Jersey: Chronics In4 Coun

  46. Slide 46: Guidance

    Slide 46: Guidance

    Guidance

  47. Slide 47: Transition Progress

    Slide 47: Transition Progress

    Transition Progress

  48. Slide 48: Requirements

    Slide 48: Requirements

    Requirements = Reserve Requirements = Captive insurance company Ratio 10 -1 requirement » NJHMO 300% Risk Based Capital requirement = Due Diligence by New Jersey Department of Banking & Insurance = Meet reserve needs and financial stability

  49. Slide 49: Infrastructure Progress

    Slide 49: Infrastructure Progress

    Infrastructure Progress

  50. Slide 50

    Slide 50

  51. Slide 51: QMedCare Conclusion

    Slide 51: QMedCare Conclusion

    QMedCare® Conclusion

  52. Slide 52: Investment Perspective

    Slide 52: Investment Perspective

    Investment Perspective

  53. Slide 53: Why It's Special

    Slide 53: Why It's Special

    Why It's Special

  54. Slide 54

    Slide 54

Source: SEC EDGAR · 8-K filed Nov 9, 2006

More decks from QMed Inc